Your browser is no longer supported. Please, upgrade your browser.
PTE PolarityTE, Inc. daily Stock Chart
PolarityTE, Inc.
Index- P/E- EPS (ttm)-5.69 Insider Own35.10% Shs Outstand20.93M Perf Week1.46%
Market Cap349.53M Forward P/E- EPS next Y-3.40 Insider Trans- Shs Float10.05M Perf Month24.16%
Income-74.20M PEG- EPS next Q-1.09 Inst Own54.10% Short Float72.87% Perf Quarter14.38%
Sales1.60M P/S218.46 EPS this Y81.70% Inst Trans0.01% Short Ratio23.85 Perf Half Y-18.42%
Book/sh3.84 P/B4.35 EPS next Y19.40% ROA-120.80% Target Price47.50 Perf Year-24.16%
Cash/sh3.39 P/C4.92 EPS next 5Y15.00% ROE-288.00% 52W Range11.54 - 41.22 Perf YTD23.80%
Dividend- P/FCF- EPS past 5Y17.60% ROI-83.40% 52W High-59.49% Beta1.20
Dividend %- Quick Ratio13.70 Sales past 5Y-49.40% Gross Margin35.90% 52W Low44.71% ATR1.47
Employees123 Current Ratio13.80 Sales Q/Q- Oper. Margin- RSI (14)60.62 Volatility9.48% 9.77%
OptionableYes Debt/Eq0.01 EPS Q/Q96.00% Profit Margin- Rel Volume0.46 Prev Close16.29
ShortableYes LT Debt/Eq0.01 EarningsJan 14 BMO Payout- Avg Volume307.03K Price16.70
Recom2.00 SMA2010.81% SMA5015.63% SMA200-17.19% Volume139,779 Change2.52%
Dec-20-18Initiated Piper Jaffray Overweight
Jan-14-19 07:00AM  PolarityTE Reports Fourth Quarter and Fiscal Year 2018 Results PR Newswire
Jan-07-19 08:00AM  PolarityTE Expands Contract Services Business with Addition of Jon Burrows PR Newswire -6.13%
Jan-03-19 08:00AM  PolarityTE to Report Fiscal Fourth Quarter Financial Results on January 14, 2019 PR Newswire
Dec-28-18 08:00AM  PolarityTE Registers OsteoTE with U.S. Food and Drug Administration PR Newswire
Dec-27-18 08:00AM  PolarityTE to Participate in Corporate Access Event in San Francisco, January 7-9, 2019 PR Newswire
Dec-24-18 10:21AM  Investors Are Undervaluing PolarityTE, Inc. (NASDAQ:PTE) By 32.74% Simply Wall St.
Dec-19-18 08:00AM  PolarityTE and University Hospitals Cleveland Medical Center Announce System-Wide Approval of SkinTE PR Newswire +8.85%
Dec-11-18 08:00AM  PolarityTE Announces Former FDA Official and Johnson & Johnson Executive Minnie Baylor-Henry Joins Board of Directors PR Newswire +17.64%
Dec-04-18 08:00AM  PolarityTE to Present SkinTE Clinical Outcomes at Innovations in Wound Healing Conference PR Newswire -7.19%
Nov-29-18 08:00AM  PolarityTE Announces Recognition of SkinTE as Finalist for Fierce Innovation Awards Biotech Innovation PR Newswire
Nov-27-18 07:00AM  PolarityTE Announces Matt Kemp as Chief Commercial Officer PR Newswire
Nov-21-18 08:00AM  PolarityTE Receives Unique HCPCS Q-Code for SkinTE for Product Reimbursement from CMS PR Newswire +8.31%
Nov-15-18 08:00AM  PolarityTE to Participate in Piper Jaffray 30th Annual Healthcare Conference PR Newswire
Nov-14-18 08:00AM  PolarityTE to Participate in Evercore ISI Healthcare Conference PR Newswire
Nov-07-18 08:00AM  PolarityTE to Sponsor Epidermolysis Bullosa Research Partnership Event "ACTion for Jackson" in New York PR Newswire
Nov-02-18 08:00AM  PolarityTE® to Participate in the Canaccord Genuity Medical Technologies and Diagnostics Forum PR Newswire
Nov-01-18 08:00AM  PolarityTE® Announces Presentation of SkinTE Clinical Outcomes at Symposium on Advanced Wound Care PR Newswire
Oct-29-18 03:02PM  Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against PolarityTE, Inc. (PTE) and Encourages PTE Investors to Contact the Firm GlobeNewswire
08:00AM  PolarityTE® Supports Development of Utah Biotech and Life Sciences Community PR Newswire
Oct-18-18 12:29PM  PolarityTE Issues Statement on Misleading Internet Post PR Newswire -17.05%
08:00AM  PolarityTE® Announces Former Acelity Leader Sharon Whalen as Vice President of Market Access PR Newswire
Oct-15-18 07:24PM  Robbins Arroyo LLP: PolarityTE, Inc. (PTE) Misled Shareholders According to a Class Action Business Wire +8.76%
Oct-12-18 08:02AM  Moving Average Crossover Alert: PolarityTE (PTE) Zacks -9.81%
Oct-09-18 10:52AM  Cool Mara Riot, Part Two: Securities-Fraud Case Against South Florida Group Reverberates Through Additional Companies Benzinga
09:15AM  PolarityTE® Announces Reporting of Apparent Intentional Market Manipulation by Third Parties to Regulatory Authorities PR Newswire
Oct-05-18 08:00AM  PolarityTE® to Present at the DFCon 2018 Diabetic Foot Global Conference on Clinical Outcomes Associated with SkinTE PR Newswire
Sep-26-18 08:00AM  PolarityTE Announces the Expansion of the Sales Team in the Regional Market Release of SkinTE PR Newswire -10.27%
Sep-24-18 08:00AM  PolarityTE Announces Presentations of SkinTE Clinical Results at Upcoming Plastic Surgery Conferences PR Newswire
Sep-20-18 08:00AM  PolarityTE to Participate in the 2018 Cantor Fitzgerald Global Healthcare Conference PR Newswire +13.37%
Mar-23-18 05:08AM  Should Parcel Technik SA.s (WSE:PTE) Recent Earnings Decline Worry You? Simply Wall St.
PolarityTE, Inc. operates as a biotechnology and regenerative biomaterials company in the United States. The company focuses on discovering, designing, and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.